Skip to main content
. 2015 May 15;191(10):1147–1157. doi: 10.1164/rccm.201412-2323OC

Table 3.

Therapies Used within the 48-Hour Data Collection Window

Therapy Total
Vasoactive infusions* 314 (55)
 Dopamine 102 (32)
 Dobutamine 20 (6)
 Epinephrine 134 (43)
 Norepinephrine 133 (42)
 Vasopressin 31 (10)
 Phenylephrine 2 (<1)
 Milrinone 95 (30)
 Vasodilator 9 (3)
Invasive mechanical ventilation 421 (74)
Corticosteroids 242 (45)
Albumin 135 (24)
Synthetic colloid 22 (4)
Blood products§ 232 (41)
Nutrition, enteral 331 (58)
Nutrition, parenteral 221 (39)
Gastric stress ulcer prophylaxis 445 (78)
Insulin 57 (10)
G/GM-CSF 23 (4)
IVIG 38 (7)
RRT 81 (14)
Plasma exchange 5 (1)
ECMO 30 (5)

Definition of abbreviations: ECMO = extracorporeal membrane oxygenation; G/GM-CSF = granulocyte/granulocyte–monocyte colony–stimulating factor; IVIG = intravenous immunoglobulin; RRT = renal replacement therapy.

Data are presented as n (%).

*

Includes dopamine >5 μg/kg/min, dobutamine >5 μg/kg/min, or any dose of epinephrine, norepinephrine, vasopressin, phenylephrine, milrinone, levosimendan, or a vasodilator.

Denominator is the number of patients receiving any vasoactive infusion (n = 314).

Vasodilators include nitroprusside, nitroglycerin, and nicardipine.

§

Includes packed red blood cells, platelets, fresh frozen plasma, cryoprecipitate, granulocytes, and whole blood.

Includes intravenous insulin by continuous infusion only.

Includes hemodialysis, all continuous renal replacement modalities, and peritoneal dialysis.